SEC Company Response from Zeo ScientifiX, Inc. (ZEOX) (CIK 0001557376) (ZEOX) — Oct 20, 2022

Zeo ScientifiX, Inc. (ZEOX) (CIK 0001557376)
Date: Oct. 20, 2022 · CIK: 0001557376 · Accession: 0001829126-22-018147

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-267563

Date

Oct. 20, 2022

Author

ORGANICELL

Form

CORRESP

Company

Zeo ScientifiX, Inc. (ZEOX) (CIK 0001557376)

Letter

Organicell Regenerative Medicine, Inc.

SW 33rd Street, Suite 246

Davie, Florida, 33314

October 20, 2022

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

“F” Street, N.E.

Washington, D.C. 20549-3629

Attention: Mr. Gregory Herbers

Re: Organicell Regenerative Medicine, Inc. (the Company”)

Registration Statement on Form S-1

File No. 333-267563

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the Company respectfully requests that the effective date of the Registration Statement is accelerated so that it will become effective at 4:00 p.m. Eastern Time on Monday, October 24, 2022, or as soon thereafter as practicable.

If you have any further questions or comments, kindly contact the undersigned at (310) 200-9741 or our counsel, Dale S. Bergman, Esq. at (305) 495-4157.

Very
truly yours,
ORGANICELL
REGENERATIVE MEDICINE, INC.

Show Raw Text

CORRESP
1
filename1.htm

Organicell
Regenerative Medicine, Inc.

7595
SW 33rd Street, Suite 246

Davie,
Florida, 33314

October
20, 2022

VIA
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
“F” Street, N.E.

Washington,
D.C. 20549-3629

Attention:
Mr. Gregory Herbers

Re:
Organicell Regenerative Medicine, Inc. (the Company”)

Registration
Statement on Form S-1

File
No. 333-267563

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the Company respectfully requests that
the effective date of the Registration Statement is accelerated so that it will become effective at 4:00 p.m. Eastern Time on Monday,
October 24, 2022, or as soon thereafter as practicable.

If
you have any further questions or comments, kindly contact the undersigned at (310) 200-9741 or our counsel, Dale S. Bergman, Esq. at
(305) 495-4157.

Very
truly yours,

ORGANICELL
REGENERATIVE MEDICINE, INC.

    By:
    /s/
    Ian Bothwell

    Ian
    Bothwell, Chief Financial Officer

SecProbe.io